Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 May;15(5):642–645. doi: 10.1128/aac.15.5.642

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

Clyde S Crumpacker 1, Lowell E Schnipper 2, John A Zaia 3, Myron J Levin 3
PMCID: PMC352730  PMID: 230783

Abstract

Inhibition by acycloguanosine (ACG) of plaque formation by harpes simplex virus types 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus, and cytomegalovirus was studied. Seventeen clinical isolates of HSV-1 were inhibited by ACG at a mean 50% inhibitory dose (ID50) of 0.15 ± 0.09 μM. The mean ID50 for 10 isolates of HSV-2 was 1.62 ± 0.76 μM, and for four isolates of varicella-zoster virus it was 3.75 ± 1.30 μM. The ID50's for two cytomegalovirus isolates were 100 and 160 μM, and for four additional isolates of cytomegalovirus no end point (ID50) was reached at 200 μM. ACG at a concentration of 200 μM had no effect on deoxyribonucleic acid synthesis in human fibroblast cells and only inhibited thymidine incorporation by Vero cells by one-third. These studies demonstrated the antiviral activity of ACG against clinical isolates of HSV-1, HSV-2, and varicella-zoster virus and the lack of toxicity to monkey or human cells in culture at concentrations which markedly inhibited these viruses. ACG had little effect on cytomegalovirus at concentrations in excess of 100 μM.

Full text

PDF
642

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel R., Jr, Kaufman H. E., Sugar J. Intravenous adenine arabinoside against herpes simplex keratouveitis in humans. Am J Ophthalmol. 1975 Apr;79(4):659–664. doi: 10.1016/0002-9394(75)90807-7. [DOI] [PubMed] [Google Scholar]
  2. Arvin A. M., Feldman S., Merigan T. C. Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial. Antimicrob Agents Chemother. 1978 Apr;13(4):605–607. doi: 10.1128/aac.13.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aswell J. F., Allen G. P., Jamieson A. T., Campbell D. E., Gentry G. A. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. Antimicrob Agents Chemother. 1977 Aug;12(2):243–254. doi: 10.1128/aac.12.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bader C., Crumpacker C. S., Schnipper L. E., Ransil B., Clark J. E., Arndt K., Freedberg I. M. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis. 1978 Dec;138(6):897–905. doi: 10.1093/infdis/138.6.897. [DOI] [PubMed] [Google Scholar]
  5. De Maeyer-Guignard J., Cachard A., De Maeyer E. Delayed-type hypersensitivity to sheep red blood cells: inhibition of sensitization by interferon. Science. 1975 Nov 7;190(4214):574–576. doi: 10.1126/science.1188355. [DOI] [PubMed] [Google Scholar]
  6. Dolin R., Reichman R. C., Mazur M. H., Whitley R. J. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep;89(3):375–388. doi: 10.7326/0003-4819-89-3-375. [DOI] [PubMed] [Google Scholar]
  7. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Feldman S., Hughes W. T., Daniel C. B. Varicella in children with cancer: Seventy-seven cases. Pediatrics. 1975 Sep;56(3):388–397. [PubMed] [Google Scholar]
  9. Gentry G. A., Aswell J. F. Inhibition of herpes simplex virus replication by araT. Virology. 1975 May;65(1):294–296. doi: 10.1016/0042-6822(75)90034-3. [DOI] [PubMed] [Google Scholar]
  10. Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
  11. Hirsch M. S., Ellis D. A., Black P. H., Monaco A. P., Wood M. L. Immunosuppressive effects of an interferon preparation in vivo. Transplantation. 1974 Feb;17(2):234–236. doi: 10.1097/00007890-197402000-00014. [DOI] [PubMed] [Google Scholar]
  12. Huang Y. T., Huang E. S., Pagano J. S. Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol. 1974 Feb;112(2):528–532. [PubMed] [Google Scholar]
  13. Jones B. R., Coster D. J., Falcon M. G., Cantell K. Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet. 1976 Jul 17;2(7977):128–128. doi: 10.1016/s0140-6736(76)92850-6. [DOI] [PubMed] [Google Scholar]
  14. Kern E. R., Richards J. T., Overall J. C., Jr, Glasgow L. A. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate. J Infect Dis. 1977 Apr;135(4):557–567. doi: 10.1093/infdis/135.4.557. [DOI] [PubMed] [Google Scholar]
  15. Merigan T. C., Rand K. H., Pollard R. B., Abdallah P. S., Jordan G. W., Fried R. P. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 4;298(18):981–987. doi: 10.1056/NEJM197805042981801. [DOI] [PubMed] [Google Scholar]
  16. Müller W. E., Zahn R. K., Bittlingmaier K., Falke D. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci. 1977 Mar 4;284:34–48. doi: 10.1111/j.1749-6632.1977.tb21935.x. [DOI] [PubMed] [Google Scholar]
  17. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. II. N Engl J Med. 1973 Oct 4;289(14):719–725. doi: 10.1056/NEJM197310042891404. [DOI] [PubMed] [Google Scholar]
  18. Prusoff W. H., Ward D. C. Nucleoside analogs with antiviral activity. Biochem Pharmacol. 1976 Jun 1;25(11):1233–1239. doi: 10.1016/0006-2952(76)90083-6. [DOI] [PubMed] [Google Scholar]
  19. Renis H. E. 5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses. Antimicrob Agents Chemother. 1978 Apr;13(4):613–617. doi: 10.1128/aac.13.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  21. Stalder H., Oxman M. N., Herrmann K. L. Herpes simplex virus microneutralization: a simplification of the test. J Infect Dis. 1975 Apr;131(4):423–430. doi: 10.1093/infdis/131.4.423. [DOI] [PubMed] [Google Scholar]
  22. Urbaniak S. J., Halliday I. M., Beveridge G. W., Kay A. V. Neutropenia and thrombocytopenia after repeated courses of leucocyte interferon. Lancet. 1978 Mar 11;1(8063):553–554. doi: 10.1016/s0140-6736(78)90574-3. [DOI] [PubMed] [Google Scholar]
  23. Whitley R. J., Ch'ien L. T., Dolin R., Galasso G. J., Alford C. A., Jr Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27;294(22):1193–1199. doi: 10.1056/NEJM197605272942201. [DOI] [PubMed] [Google Scholar]
  24. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES